Neurogene NGNE
$25.31 −$0.34 (-1.33%)
Market closed · Nov 6, 8:20 pm ET · Last extended-hours $25.31 0.00%
Open$26.33
Prev close$25.65
Day range$24.68 – $27.26
Volume324.9K
Market cap$506.49M
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts8
Average target$80.17+216.8% vs. price
- Buy 100%
Low $46.00Now $25.31Avg $80.17High $166.00
Recent rating changes
The last 20 actions on file set price targets from $46.00 to $180.00, averaging $80.76.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 28 Oct 2026 | CCORF | BUY | $166.00 |
| 28 Oct 2026 | H.C. Wainwright | BUY | $65.00 |
| 8 Oct 2026 | Stifel | BUY | $46.00 |
| 8 Oct 2026 | J.P. Morgan | BUY | $60.00 |
| 13 Aug 2026 | Stifel | BUY | $46.00 |
| 12 Aug 2026 | CCORF | BUY | $166.00 |
| 12 Aug 2026 | H.C. Wainwright | BUY | $65.00 |
| 11 Aug 2026 | TD Cowen | BUY | – |
| 11 Aug 2026 | LifeSci Capital | BUY | $63.00 |
| 11 Aug 2026 | William Blair | BUY | – |
| 11 Aug 2026 | Guggenheim | BUY | $81.00 |
| 11 Jul 2026 | LifeSci Capital | BUY | $65.00 |
| 7 Jul 2026 | LifeSci Capital | BUY | $65.00 |
| 6 Jul 2026 | Stifel | BUY | $46.00 |
| 30 Jun 2026 | Guggenheim | BUY | $69.00 |
| 30 Jun 2026 | H.C. Wainwright | BUY | $70.00 |
| 29 Jun 2026 | CCORF | BUY | $180.00 |
| 29 Jun 2026 | LifeSci Capital | BUY | $60.00 |
| 29 Jun 2026 | William Blair | BUY | – |
| 22 Jun 2026 | LifeSci Capital | BUY | $60.00 |
No comments yet — be the first to weigh in on NGNE.